AdverseEvent.ai
This page presents data from the FDA Adverse Event Reporting System (FAERS) and the FDA-approved drug label. A report submitted to FAERS does not prove a drug caused the reported event. Always consult a healthcare provider about medications.

Nicotine Polacrilex (nicotine)

cholinergic nicotinic agonist
Last updated: June 5, 2026

Nicotine Polacrilex is the brand name for nicotine, a cholinergic nicotinic agonist. According to the FDA-approved label, reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking. FAERS contains 39,874 submissions naming this drug from 2004 through 2026; the top three reactions cited are drug ineffective, nausea, and application site erythema.

Most-Reported Reactions

Counts of the reactions most often cited in FAERS submissions that named Nicotine Polacrilex. Inclusion here does not establish causation - submitters describe what was observed, not what was confirmed. One submission can list several reactions, so the totals exceed the report count.

DRUG INEFFECTIVE 5,217 NAUSEA 3,245 APPLICATION SITE ERYTHEMA 3,136 APPLICATION SITE PRURITUS 3,064 NICOTINE DEPENDENCE 2,747 DIZZINESS 1,898 MALAISE 1,630 HEADACHE 1,628 VOMITING 1,248 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1,237 DYSPNOEA 1,130 INSOMNIA 1,111 APPLICATION SITE IRRITATION 1,106 OVERDOSE 1,075 ANXIETY 1,074

Submissions Per Quarter

Quarterly count of FAERS submissions that named Nicotine Polacrilex. Ups and downs on this chart can track prescribing volume, news cycles, or shifts in how reports get filed, rather than the drug becoming safer or more dangerous.

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

From the FDA-Approved Label

Excerpts from the official FDA-approved prescribing information for Nicotine Polacrilex. This is the authoritative source on indications, warnings, and known adverse reactions.

Indications

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known. Ask a doctor before use if you have a sodium-restricted diet heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate. high blood pressure not controlled with medication. Nicotine can increase your blood pressure. stomach ulcer or diabetes history of seizures Ask a doctor or pharmacist before use if you are using a non-nicotine stop smoking drug taking prescription medicine for depression or asthma. Your prescription dose may need to be adjusted. Stop use and ask doctor if mouth problems occur persistent indigestion or severe sore throat occurs irregular heartbeat or palpitations occur you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat you have symptoms of an allergic reaction (such as difficulty breathing or rash) Keep out of reach of children an...

FDA label effective date: 2024-07-04

Disclaimer

AdverseEvent.ai is not affiliated with the FDA. Adverse-event counts come from the FDA Adverse Event Reporting System (FAERS). Drug labels come from the FDA drug label dataset. A report submitted to FAERS does not prove a drug caused the reported event — always consult a healthcare provider about medications. This site is for informational purposes only and is not medical advice.